Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT04429009
Other study ID # ZEPHYRx Rochester
Secondary ID
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date September 1, 2021
Est. completion date September 30, 2023

Study information

Verified date August 2022
Source My Music Machines Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The primary aim of this randomized control trial is to analyze by direct comparison the ZEPHYRx Respiratory Therapy (RT) system and the FDA approved standard of care (SOC) incentive spirometer (IS), used for FDA approved indications at the University of Rochester Medical Center (URMC). This comparison will determine subject preferences in terms of usability and simplicity of each, as well as subject engagement and adherence to the prescribed respiratory therapy routine. Additionally, the study will analyze the effectiveness of the gamified spirometry with regards to spirometry volumes, frequency of usage, and pulmonary complications 30 days post discharge.


Description:

Lobectomy and wedge resection patients at University of Rochester Medical Center meeting the eligibility criteria will be screened and consented by members of the research team prior to surgery at their pre-operative clinic visit. Once a subject meets the inclusion criteria for this study, the subject will be randomly assigned to one of the two arms of this study by a flip of a coin. To ensure that we meet the predicted 50 subjects in each arm of the study, every second subject enrolled will be assigned to the opposite arm of the previously assigned subject. Subjects enrolled in the study arm: Following surgery or extubation, and once no longer under the influence of anesthesia, the patient enrolled into the study arm will be provided with a ZEPHYRx incentive spirometer device connected to an Amazon Kindle Fire HD Tablet. A respiratory therapist, nurse, doctor, or research team member will teach the subject how to use the device and the tablet, and walk them through the first series of breaths. A built-in bell reminder in the device will ring once every hour between the hours of 8:00 a.m. and 8:00 p.m. to remind patients to use the device, this feature is part of the research and a feature programmed into the device. Additionally, subjects will answer questions on their tablet about pain level on a scale of 0-10 before and after each round of game play. At discharge, the subjects in the study arm will return their assigned tablet and will be issued a standard incentive spirometer to continue respiratory therapy at home, per standard of care. Subjects in the study arm will not be held responsible for lost, stolen or damaged tablets or incentive spirometers. The subject in the study arm may choose to keep or discard the ZEPHYRx incentive spirometer device. The device will record subject usage, including number of breaths, number of sessions, total time the device was in use, inspiratory volumes, and pain level (0-10) before and after each round of game play. Subjects enrolled in the control arm: Following surgery or extubation, and once no longer under the influence of anesthesia, the patient enrolled in the control arm will meet with an RT, nurse, doctor, or research team member to receive an FDA approved incentive spirometry device and appropriate training thus initiating the study. Routine respiratory care involves the use of a standard incentive spirometer that is not a digital device and does not include any built-in reminder. As per routine care, the nurse or respiratory therapist will remind the subjects in both arms of the study to perform their respiratory therapy of at least 10 breaths per hour. In order to obtain data comparable to what the ZEPHYRx respiratory therapy system will collect, similar data will be collected from subjects in the control arm on a data sheet by an RT, nurse, doctor, or research team member 3 times a day until the subject is discharged. The only questionnaire will be the standard of care pain scale questions which the subjects in the control arm will have to complete in written form. Upon discharge, subjects in the control arm of the study will be allowed to keep their standard of care incentive spirometer in order to continue respiratory therapy at home, per standard of care. Subjects in the control arm will not be held responsible for lost, stolen or damaged incentive spirometers. On a daily basis, a member of the research team will check that the device(s) is/are working correctly and will answer any questions the subject may have regarding the study or device.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 100
Est. completion date September 30, 2023
Est. primary completion date August 31, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - Adult Patients ages 18+ undergoing thoracic lobectomy surgery or wedge resection for tumor/nodule excisionat the University of Rochester Medical Center. Exclusion Criteria: - Patients under the age of 18 - Patients with diminished physical or mental capacity that make them incapable of operating a standard spirometer device - Patients with visual or hearing impairments that make it difficult to understand verbal or written instructions - Patients who are not able to read the language the ZEPHYRx software is available in (currently available only in English)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
ZEPHYRx Respiratory Therapy (RT) System
A breath controlled video game system for respiratory therapy
Standard Incentive Spirometer
A simple (not digital) plastic device that contains a piston that rises inside the device and measures the volume of your breath

Locations

Country Name City State
United States University of Rochester Medical Center Rochester New York

Sponsors (2)

Lead Sponsor Collaborator
My Music Machines Inc. University of Rochester

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Adherence to prescribed spirometry routine Number of deep breaths taken per day with the prescribed device From extubation post-surgery to hospital discharge (estimated average of 2-4 days)
Primary Lung Volume Average daily inspiratory volume of the breaths taken with the prescribed device. Recorded 3 times per day by nurse or RT for the control group, and recorded at each use by the device for the active study group From extubation post-surgery to hospital discharge (estimated average of 2-4 days)
Primary Hospital Readmission Hospital Readmission within 30 days of discharge 30 days post discharge
Secondary Atelectasis Degree of Atelectasis assessed from chest radiography on a 5 point scale, where high scores correspond to more severe disease (1. no apparent disease, 2. subsegmental atelectasis, 3. segmental atelectasis, 4. lobar atelectasis, or 5. pneumonia) Evaluated for any required x-ray procedures during length of post-operated hospital stay (estimated 2-4 days per patient)
Secondary Device Usability A brief survey including likert scale questions on usability, and open ended feedback. Questions will be asked on a 5 point scale (1. strongly agree, 2. somewhat agree, 3. Neutral, 4. somewhat disagree, strongly disagree), with lower scores corresponding to better acceptance of the device. At time of discharge (estimated to be 2-4 days post surgery extubation)
Secondary Pain Scale pre and post exercises A measure of pain on the 0-10 Wong-Baker FACES pain scale that uses images of faces to determine pain level. 0 = no hurt (happy face), 10 = worst hurt (crying face) Recorded before and after each session with the device for the treatment group, and by a nurse via paper survey 3 times per day for the control group during the length of hospital stay (estimated 2-4 days per patient)
Secondary Length of Stay Post Operative Hospital Length of Stay From extubation post-surgery to hospital discharge (estimated average of 2-4 days)
See also
  Status Clinical Trial Phase
Recruiting NCT04865874 - GDT-PPV Protocol in Thoracic Surgery N/A
Active, not recruiting NCT02715271 - Study of TB Lesions Obtained in Therapeutical Surgery
Completed NCT02964026 - Study of Clinical Outcomes Associated With the Pulmonary Artery Catheter (PAC) in Cardiac Surgery Patients N/A
Completed NCT02919267 - Physiology of Lung Collapse Under One-Lung Ventilation: Underlying Mechanisms N/A
Recruiting NCT03165539 - Cerebral Oxygen Desaturation and Post-Operative Delirium in Thoracic Surgical Patients
Terminated NCT01320475 - Epidural Levobupivacaine-sufentanil Versus Epidural Levobupivacaine and Intravenous Ketamine Phase 4
Recruiting NCT05045196 - Health-promoting Family Conversations and Open Heart Surgery N/A
Completed NCT04507958 - Electronic Stethoscope Use During Intubation in Full Personal Protective Equipment
Recruiting NCT05060302 - Prognosis of Right Ventricular Dysfunction Assessed by Speckle Tracking in Postoperative Thoracic Surgery N/A
Completed NCT05667467 - The Effect of Care Bundle in Heart Surgery N/A
Not yet recruiting NCT03275428 - THRIVE and Non-intubated Thoracic Surgery N/A
Not yet recruiting NCT05482230 - Application of Tracheal Intubation in Lateral Position in Thoracic Surgery N/A
Not yet recruiting NCT03628040 - Erector Spinae Plane Block for Video-assisted Thoracoscopic Surgery Phase 3
Recruiting NCT03300622 - Assessment in Patients After Thoracic Surgery N/A
Completed NCT00981474 - Cerebral Autoregulation Monitoring During Cardiac Surgery N/A
Completed NCT03309280 - Influence of Different Parameters on Extubation Time After Cardiac Surgery.
Recruiting NCT03820700 - Using Hypnosis and Virtual Reality During Pre and Postoperative Cardiovascular Surgery. N/A
Completed NCT03768193 - Deep Serratus Anterior Plane Block vs Surgically-placed Paravertebral Block for VATS Surgery N/A
Recruiting NCT04609228 - Cardiac Surgery Outcomes in Blood-transfusion Acceptors and no Acceptors
Completed NCT05695404 - Contribution of 3D Printing in Anatomical Lung Segmentectomies.